LSE - Delayed Quote EUR

Oriola Oyj (0NES.L)

1.0840
-0.0060
(-0.55%)
At close: 3:40:02 PM GMT+1
Loading Chart for 0NES.L
  • Previous Close 1.0900
  • Open 1.0840
  • Bid --
  • Ask --
  • Day's Range 1.0800 - 1.0840
  • 52 Week Range 0.8940 - 1.5340
  • Volume 8,188
  • Avg. Volume 8,122
  • Market Cap (intraday) 197.515M
  • Beta (5Y Monthly) 0.43
  • PE Ratio (TTM) 0.09
  • EPS (TTM) 0.1170
  • Earnings Date Jul 18, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company also distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs and quality, medical and scientific affairs, market access and tenders, real world evidence, sales support, medical translation, pharmacovigilance and medical information, and patient support services. Further, the company provides advisory services. It serves pharmaceutical companies, pharmacies, veterinarians, hospitals, healthcare providers, special stores, retailers, and e-commerce companies. Oriola Oyj was founded in 1907 and is headquartered in Espoo, Finland.

oriola.com

845

Full Time Employees

December 31

Fiscal Year Ends

--

Sector

--

Industry

Recent News: 0NES.L

View More

Performance Overview: 0NES.L

Trailing total returns as of 6/11/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

0NES.L
22.66%
MSCI WORLD (^990100-USD-STRD)
5.98%

1-Year Return

0NES.L
0.00%
MSCI WORLD (^990100-USD-STRD)
12.92%

3-Year Return

0NES.L
39.75%
MSCI WORLD (^990100-USD-STRD)
48.74%

5-Year Return

0NES.L
39.23%
MSCI WORLD (^990100-USD-STRD)
82.39%

Compare To: 0NES.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0NES.L

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.32%

  • Return on Assets (ttm)

    0.48%

  • Return on Equity (ttm)

    -16.32%

  • Revenue (ttm)

    1.75B

  • Net Income Avi to Common (ttm)

    -23.2M

  • Diluted EPS (ttm)

    0.1170

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    134.6M

  • Total Debt/Equity (mrq)

    52.94%

  • Levered Free Cash Flow (ttm)

    69.12M

Research Analysis: 0NES.L

View More

Company Insights: 0NES.L

Research Reports: 0NES.L

View More